Schlit AF et al. |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. |
1995 |
Contraception |
pmid:7750285
|
Nüsing RM et al. |
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. |
2001 |
Clin. Pharmacol. Ther. |
pmid:11673754
|
Renda G et al. |
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. |
2006 |
Clin. Pharmacol. Ther. |
pmid:16952493
|
Lee CR et al. |
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. |
2008 |
Clin. Pharmacol. Ther. |
pmid:17495879
|
Cipollone F et al. |
Effects of nabumetone on prostanoid biosynthesis in humans. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7554708
|
Oosaki R et al. |
Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. |
1998 |
Clin. Exp. Allergy |
pmid:9761018
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
Gonçalves LH et al. |
Urinary 11-dehydro thromboxane Bâ‚‚ levels in type 2 diabetic patients before and during aspirin intake. |
2011 |
Clin. Chim. Acta |
pmid:21510926
|
Lowe FJ et al. |
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. |
2009 |
Clin. Chem. Lab. Med. |
pmid:19676143
|
Karon BS et al. |
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. |
2008 |
Clin. Chem. |
pmid:18420732
|